Stay updated on Pembrolizumab in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent HNSCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing the previous v3.6.4 tag to reflect an updated platform version. This change is a metadata update and does not alter the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-08-08T16:57:49.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new release of the page content. This update documents a version change rather than affecting user-facing information.
    Difference
    0.1%
    Check dated 2026-07-25T09:24:25.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    A new page revision tag (v3.6.3) has replaced the previous v3.6.2 on the study record page, indicating a minor update to the page. The update reflects a version change rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-07-03T22:55:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2 on the page, indicating a newer version of the study record interface.
    Difference
    0.1%
    Check dated 2026-06-26T23:22:06.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The study page gains a recruitment status update ('No longer looking for participants'), which directly affects enrollment. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision note to v3.6.0, while the prior revision note v3.5.5 is removed and the heading 'Intervention/Treatment' is adjusted.
    Difference
    0.4%
    Check dated 2026-06-12T14:25:43.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing v3.5.4. This indicates a small update to the page's metadata or formatting without altering the study details or data.
    Difference
    0.1%
    Check dated 2026-06-05T10:26:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.